A Combination of Zarnestra With Velcade for Patients With Relapsed Multiple Myeloma

This study has been terminated.
(Initial Principal Investigator left Moffitt)
Sponsor:
Collaborators:
Millennium Pharmaceuticals, Inc.
Information provided by:
H. Lee Moffitt Cancer Center and Research Institute
ClinicalTrials.gov Identifier:
NCT00361088
First received: August 3, 2006
Last updated: November 21, 2013
Last verified: May 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: June 2007
  Primary Completion Date: June 2007 (Final data collection date for primary outcome measure)